A Safety, Tolerability, and Pharmacokinetics (PK) Study of AGN-223575 in Healthy Subjects

This study will evaluate the safety, tolerability, and pharmacokinetics (PK) of AGN-223575 in healthy subjects.

Inclusion Criteria:

• Weight at least 110 lbs

Exclusion Criteria:

• Use of contact lenses within 14 days, or planned use during the study
• Use of any ocular eye medications within 30 days, or anticipated use during the study
• Anticipated use of any artificial tears product during the study